Hair Growth Foam Aerosol, Foam
NDC Package 83804-008-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Hair Growth Foam (minoxidil) aerosols is minoxidil is used with other medications to treat high blood pressure (hypertension). This formulation utilizes a aerosol, foam delivery system. Marketed by Shenzhen Shandian Jingling Technology Co., Ltd., this product is identified by NDC 83804-008 and is authorized under FDA application 505G(a)(3).

Identification & Billing

NDC Package Code
83804-008-01
Package Description
60 mL in 1 BOTTLE
Product Code
83804-008
11-Digit Billing Format
83804000801
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Hair Growth Foam
Non-Proprietary Name
Minoxidil
Substance Name
Minoxidil
Dosage Form
Aerosol, Foam - A dosage form containing one or more active ingredients, surfactants, aqueous or nonaqueous liquids, and the propellants; if the propellant is in the internal (discontinuous) phase (i.e., of the oil-in-water type), a stable foam is discharged, and if the propellant is in the external (continuous) phase (i.e., of the water-in-oil type), a spray or a quick-breaking foam is discharged.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
MINOXIDIL 5 g/100mL
Pharmacologic Class
Usage Information
Minoxidil is used with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Minoxidil works by relaxing blood vessels so blood can flow more easily.

Regulatory & Marketing

Labeler Name
Shenzhen Shandian Jingling Technology Co., Ltd.
Product Type
Human Otc Drug
FDA Application #
505G(a)(3)
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-22-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83804-008-01 identifies a specific commercial package of 60 ml in 1 bottle of Hair Growth Foam, a human over the counter drug labeled by Shenzhen Shandian Jingling Technology Co., Ltd.. This aerosol, foam is formulated for topical use and contains minoxidil as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Shenzhen Shandian Jingling Technology Co., Ltd. on August 22, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Minoxidil is used with other medications to treat high blood pressure (hypertension). Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Minoxidil works by relaxing blood vessels so blood can flow more easily.

How is this Shenzhen Shandian Jingling Technology Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83804000801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83804-008-01
11-Digit CMS (5-4-2)
83804-0008-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.